From: Impact of delays in radiotherapy of head and neck cancer on outcome
Parameter | HR | 95% CI | P-value |
---|---|---|---|
Locoregional control | |||
TNM (III vs. I-II) | 0.843 | 0.369–1.925 | 0.685 |
TNM (IV vs. I-II) | 2.320 | 1.211–4.444 | 0.011 |
Age | 0.976 | 0.950–1.002 | 0.075 |
TTI | 1.012 | 0.998–1.027 | 0.094 |
Gender | 0.501 | 0.201–1.249 | 0.138 |
Therapy (CCT vs. RT) | 0.768 | 0.444–1.328 | 0.344 |
Cause specific hazard | |||
TNM (III vs. I-II) | 3.203 | 1.286–7.976 | 0.012 |
TNM (IV vs. I-II) | 13.223 | 6.007–29.108 | < 0.001 |
Age | 0.985 | 0.965–1.005 | 0.133 |
TTI | 1.001 | 0.990–1.012 | 0.844 |
Gender | 0.907 | 0.529–1.556 | 0.724 |
Therapy (CCT vs. RT) | 0.534 | 0.369–0.774 | 0.001 |